US OTC Drugs Market Size To Worth US$ 32.9 Billion by 2028 | IMARC Group

IMARC Group, a leading market research company, has recently releases report titled "United States Over The Counter Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" The study provides a detailed analysis of the industry, including the US OTC Drugs market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the United States Over The Counter Drugs market?

The United States over the counter (OTC) drugs market size reached US$ 24.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028.

What are Over The Counter Drugs?

Over-the-counter (OTC) drugs are medical products that are considered safe and effective for the general public to use without the need for professional healthcare supervision. They comprise analgesics, antihistamines, antacids, cough and cold medications, and dermatological products, which are used to treat various skin conditions, such as hydrocortisone creams. They are sold directly to consumers without a prescription from a healthcare provider. They are primarily used to treat minor health issues such as colds, allergies, headaches, and digestive problems. They can also be used for preventive care, such as vitamins and supplements to maintain good health. Furthermore, as OTC drugs are easily available and affordable, their demand is rising in the United States.

Request for a sample copy of this report: https://www.imarcgroup.com/united-states-over-the-counter-drugs-market/requestsample

What are the growth prospects and trends in the United States over the counter drugs industry?

At present, the increasing preference among consumers for self-medication to manage minor health issues without medical intervention represents one of the crucial factors impelling the market growth in the United States. Besides this, the rising demand for OTC drugs due to the increasing occurrence of chronic ailments is propelling the growth of the market.

In addition, the growing technological improvements in the healthcare sector, including mobile applications and online platforms that provide information about medications and facilitate OTC drug purchases, are offering a favorable market outlook in the United States. Apart from this, the increasing adoption of innovative marketing strategies that provide information and facilitate OTC drug purchases to improve their sales is supporting the growth of the market.

Additionally, the rising integration of advanced manufacturing practices and investment in research and development (R&D) endeavors to manufacture new, effective, and safe OTC drugs is bolstering the growth of the market in the United States.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product Type:
• Cough, Cold and Flu Products
• Analgesics
• Dermatology Products
• Gastrointestinal Products
• Vitamins, Minerals and Supplements (VMS)
• Weight-loss/Dietary Products
• Ophthalmic Products
• Sleeping Aids
• Others

Breakup by Route of Administration:
• Oral
• Parenteral
• Topical
• Others

Breakup by Dosage Form:
• Tablets and Capsules
• Liquids
• Ointments
• Others

Breakup by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Breakup by Region:
• Northeast
• Midwest
• South
• West

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5857&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Related Reports:

https://www.digitaljournal.com/pr/news/imarc/analog-to-digital-converters-market-share-growth-report-forecast-2023-2028

https://www.digitaljournal.com/pr/news/imarc/global-dialyzer-market-report-2023-2028-growth-outlook-leading-players-such-as-asahi-kasei-corporation-b-braun-melsungen-ag-baxter-international-inc-browndove-healthcare-p-ltd-

https://www.digitaljournal.com/pr/news/imarc/fruit-powder-market-share-analysis-industry-report-2023-2028

https://www.digitaljournal.com/pr/news/imarc/non-poultry-meat-market-in-india-2023-2028-industry-size-share-report-forecast

https://www.digitaljournal.com/pr/news/imarc/global-military-power-solutions-market-size-to-reach-us-12-2-billion-by-2028

https://www.digitaljournal.com/pr/news/imarc/ship-to-shore-cranes-market-report-2023-global-trends-forecast-2028

https://www.digitaljournal.com/pr/news/imarc/cream-cleaners-market-2023-top-companies-growth-report-global-industry-trends-2028

https://www.digitaljournal.com/pr/news/imarc/medical-waste-containers-market-is-projected-to-reach-us-3-274-million-by-2028-at-cagr-of-6-2-2023-2028-

https://www.digitaljournal.com/pr/news/imarc/industrial-x-ray-inspection-equipment-and-imaging-software-market-is-estimated-to-be-us-1-075-million-by-2028-at-cagr-of-6-7-

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.